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Abstract 
 
The applications of Fluorescence resonance energy transfer (FRET) have expanded 
tremendously in the last 25 years, and the technique has become a staple technique in many 
biological and biophysical fields. FRET can be used as spectroscopic ruler in various areas such 
as structural elucidation of biological molecules and their interactions, in vitro assays, in vivo 
monitoring in cellular research, nucleic acid analysis, signal transduction, light harvesting, and 
metallic nanomaterials etc. Based on the mechanism of FRET a variety of novel chemical 
sensors and Biosensors have been developed. This review highlights the recent applications of 
sensitive and selective ratiometric FRET based sensors.  
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1. Introduction 
The Fluorescence resonance energy transfer (FRET) has been widely used as a 
spectroscopic technique in all applications of fluorescence, including medical diagnostics, DNA 
analysis, optical imaging [1] and for various sensing properties [2-11]. Generally, fluorescence-
based sensors adopt three different strategies: (a) fluorescence quenching (turn-off), (b) 
fluorescence enhancement (turn-on), and (c) fluorescence resonance energy transfer (FRET). 
FRET sensors became popular tools for studying intracellular processes [12-16]. FRET between 
two molecules is an important physical phenomenon with considerable interest for the 
understanding of some biological systems and with potential applications in optoelectronic and 
thin film device development [17, 18]. 
In this account, we review the application of FRET for designing various sensors, 
focusing primarily on ion sensor, bio-sensor, hard water sensor and pH sensor. The technique of 
FRET, when applied to optical microscopy, permits to determine the approach between two 
molecules within several nanometers. FRET was first described over 50 years ago, that is being 
used more and more in biomedical research and drug discovery today. FRET is an 
electrodynamic phenomenon that occurs through non-radiative process whereby an excited state 
donor D (usually a fluorophore) transfers energy to a proximal ground state acceptor A through 
long-range dipole−dipole interactions [19]. The acceptor must absorb energy at the emission 
wavelength(s) of the donor but does not necessarily have to remit the energy fluorescently itself. 
The rate of energy transfer depends on a number of factors including the fluorescence quantum 
yield of the donor in the absence of acceptor, the refractive index of the solution, the dipole 
angular orientation of each molecule. FRET can be an accurate measurement of molecular 
proximity at angstrom distances (10-100Å). Due to its sensitivity to distance, FRET has been 
used to investigate molecular level interactions [20-27]. Though the physics and chemistry 
behind the fluorescence resonance energy transfer have been well studied theoretically for years 
but only with recent technical advances has it become feasible to apply FRET to sensing research 
[2-11]. Recent advances in the technique have led to qualitative and quantitative improvements, 
including increased spatial resolution, distance range and sensitivity. FRET mechanisms are also 
important to other phenomena, such as photosynthesis kinetics, chemical reactions and Brownian 
dynamics [28, 29]. Recently, FRET phenomenon have been employed for the conformation of 
proteins and knowing their structure [30], for the detection of spatial distribution and assembly 
of proteins [31], for the designing biosensor [10], for nucleic acid hybridization [32], distribution 
and transport of lipids [33]. 
One of the important methods for sensing of different chemical and biological materials 
is fluorescent sensors. In recent years, fluorescence spectroscopy has become a powerful tool for 
the detection of transition and heavy metal ions with high sensitivity and simplicity [34-37]. 
However, many of the chemosensors have only one signal for detecting, i.e., the fluorescence 
intensity, and could be easily perturbed by the environmental and instrumental conditions [38-
39]. However, it is interesting to mention that the introduction of ratiometric chemosensors can 
eliminate or reduce the effects of these factors by the self-calibration of the two emission bands 
[40-51]. Recently, the FRET has been employed to design ratiometric sensors [50, 49, 52-56]. 
The design of ratiometric sensors can be done by two method (i) ICT (intermolecular charge 
transfer) and (ii) FRET (Fluorescence Resonance Energy Transfer). For many ICT based ion 
sensors it is difficult to determine the ratio between two relatively broad signal emissions. The 
advantage of FRET over ICT is that the ratio between two fluorescence intensities is independent 
of these external factors such as fluctuation of excitation source and sensor concentration. FRET 
observed the changes in the intensity ratio of absorption and emission which is favourable in 
increasing the signal selectivity. A significant advantage of FRET-based sensing is that it 
simplifies the design of the fluorophore. Recently, FRET based sensing has become most 
effective method for the detection of ions in environment. FRET based sensors have been widely 
used in metal ion detection [57, 58], sensing of the fluorophores [59–63], Silica [64, 65], and 
polymer particles [66–68]. 
In this review, we focus on discussion of various types of chemical and biological sensors 
like pH sensor, hard water sensor, Ion sensor and DNA sensor, which were developed by the 
implementation of FRET phenomenon between two laser dyes Acriflavine (Acf) and Rhodamine 
B (RhB) mainly by our group. As both the dyes Acf & RhB are highly fluorescent and the 
fluorescence spectrum of Acf sufficiently overlaps with the absorption spectrum of RhB, they are 
in principle suitable for FRET. These phenomenons have been investigated in aqueous solution, 
clay dispersion and layer-by-layer (LbL) self assembled films. The effect of various types of ions 
(like K+, Na+, Mg+2, Ca+2, Fe+2, Fe+3, Al+3 etc) on the FRET efficiency between Acf & RhB have 
been discussed in Ion Sensor where as in pH sensor the effect of different pH has been 
investigated. Hard water sensor is able to sense the extent of hardness of water and DNA sensor 
can be very useful to detect the effect of DNA on the spectrum of Acf & RhB. Of late the 
sensing technology has been enormously enhanced due to suitable application of FRET. 
2. Principle and theoretical consideration of FRET 
In the process of FRET, initially a donor fluorophore (D) absorbs the energy due to the 
excitation of incident light and transfer the excitation energy to a nearby chromophore, the 
acceptor (A). 
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[Where h  is the Planck’s constant and υ  is the frequency of the radiation] 
Energy transfer manifests itself through decrease or quenching of the donor fluorescence 
and a reduction of excited state lifetime accompanied also by an increase in acceptor 
fluorescence intensity. Figure 1 is a Jablonski diagram that illustrates the coupled transitions 
involved between the donor emission and acceptor absorbance in FRET. In presence of suitable 
acceptor, the donor fluorophore can transfer its excited state energy directly to the acceptor 
without emitting a photon. 
 
Figure 1. Jablonski diagram illustrating the FRET process. 
There are few criteria that must be satisfied in order for FRET to occur. These are: (i) the 
fluorescence emission spectrum of the donor molecule must overlap the absorption or excitation 
spectrum of the acceptor chromophore. The degree of overlap is referred to as spectral overlap 
integral (J). (ii) The two fluorophore (donor and acceptor) must be in the close proximity to one 
another (typically 1 to 10 nanometer). (iii) The transition dipole orientations of the donor and 
acceptor must be approximately parallel to each other. (iv) The fluorescence lifetime of the 
donor molecule must be of sufficient duration to allow the FRET to occur. 
Solving the enigma surrounding fluorescence quenching experiments revealed the phenomenon 
of FRET and led J. Perrin [69] to propose dipole–dipole interactions as the mechanism via which 
molecules can interact without collisions at distances greater than their molecular diameters. 
Some 20 years later, Förster [70, 71] built upon Perrin’s idea to put forward an elegant theory 
which provided a quantitative explanation for the non-radiative energy transfer in terms of his 
famous expression given by 
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Where, ( )Tk r is the rate of energy transfer from donor to acceptor, r is the distance 
between donor and acceptor and 0R is the well-known Förster radius given by the spectral 
overlap between the fluorescence spectrum of the donor and the absorption spectrum of the 
acceptor. The distance at which resonance energy transfer is 50% efficient, is called the Förster 
distance. At r = R0, the transfer efficiency is 50% and at this distance the donor emission would 
be decreased to half of its intensity in the absence of acceptor.  
The value of R0 can be defined by the following expression [72-75] 
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Where,  
= the normalized fluorescence intensity of the donor. 
 = the extinction coefficient of the acceptor (in M-1cm-1). 
λ = the wavelength (in nm). 
 = the fluorescence quantum yield of the donor in the absence of acceptor. 
n = is the refractive index of the medium. 
k2 = orientation factor of transition dipole moment between donor (D) and acceptor (A). 
N = Avogadro number. 
The integral part of equation (2) is known as the spectral overlap integral  and is given by  
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Therefore the above definition of R0 in equation (2) can be rewritten in terms of  with units 
M-1cm-1nm4 as 
12 4 6
0 0.2108{ ( )} (4)DR k n J λ−= Φ →  
Where  is in units of . 
 The energy transfer efficiency can be termed as [72-74] ( )
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This is the fraction of the transfer rate to the total decay rate of the donor. Using equation (1) and 
(5) E can be expressed as  
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The efficiency of the energy transfer (E) can also be expressed as [57] 
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where  is the relative fluorescence intensity of donor in the presence of acceptor and  is the 
fluorescence intensity of donor in the absence of acceptor. This equation is equivalent to 
equation 5 [75]. 
3. FRET as molecular spy 
The unique feature of FRET is its capability to inform us whenever two molecules (donor 
and acceptor) are close to one another on a molecular scale (usually within 1-10 nm), and 
whether they are moving relative to each other. It is also possible to detect how the donor and 
acceptor transition moments are oriented relative to each other. This is because the FRET 
efficiency depends on donor-acceptor distance as well as on the relative orientations of the two 
dipoles. It is possible to couple FRET pair with other physical and biological methods, and this 
greatly extends the usefulness of the process. Therefore fluropore involving FRET can be 
considered as analogous to roaming molecular spies with radio transmitters, radiating 
information to the experimenter about the state of affairs on the molecular scale, and informing 
us where the spies are located and how they are oriented.  
Generally FRET (spectroscopic experiments) can be carried out in most laboratories, 
whether the ‘‘samples’’ are large (such as in cuvettes, or even on whole mammalian bodies) or 
small (such as in the fluorescence microscope, and on the single molecule level). Therefore, 
irrespective of the scale of the sample, the information on the molecular scale derivable from 
FRET remains accessible. Accordingly, FRET can be considered as like a spectroscopic 
microscope, providing us information about the distance and orientation on the molecular scale 
regardless of the size of the sample. Also it is possible to follow the dynamics of changes in 
molecular dimensions and proximities by monitoring FRET with time.  
4. Principle of FRET sensor design 
Typical FRET sensor consists of a recognition element (sensing material) fused to a pair 
of fluorophores (FRET pair) capable of FRET or a system containing the FRET pair and the 
recognition element. A conformational change in the recognition element can be exploited to 
bring about changes in FRET efficiency when fused to an appropriate FRET pair. Or presence of 
recognition element affects FRET efficiency. Also analyte dependent changes in the spectra of 
FRET pair can change the FRET efficiency [71-73]. Therefore, FRET is a unique phenomenon 
in generating fluorescence signals sensitive to molecular conformation, association and 
separation in the 1–10 nm range [72]. 
FRET is a non-radiative quantum mechanical process where energy transfer occurs 
between two fluorophores in close proximity (less than 10 nm apart) through long-range 
dipole−dipole interactions [74, 75]. The rate of energy transfer is highly dependent on many 
factors, such as the extent of spectral overlap, the relative orientation of the transition dipoles, 
and, most importantly, the distance between the donor and acceptor molecules [76, 77]. FRET 
usually occurs over distances comparable to the dimensions of most biological macromolecules, 
that is, about 10 to 100 Å. This makes FRET a spectroscopic ruler to study biological systems 
[78-80]. Since FRET is extremely sensitive to changes in the relative positions of two 
fluorophores or their orientation, even a subtle change in the conformation of the recognition 
element, when attached to a FRET pair, can be visualized as a change in FRET efficiency. Also 
presence of minute amount of recognition element may affect the FRET efficiency.  
FRET based sensing system is very appealing because of its simpleness of building 
ratiometric fluorescent systems. Unlike those of single-signal sensors, the ratiometric sensors 
contain two different fluorophores and use the ratio of the two fluorescence intensities to 
quantitatively detect the analytes. They can eliminate most ambiguities in the detection process 
by self-calibration of two emission bands. The external factors, such as excitation source 
fluctuations and concentration, will not affect the ratio between the two fluorescence intensities 
[80, 81]. 
Conventionally, the FRET-based sensing systems have been designed in the form of 
small molecular dyads, which contain two fluorophores connected by a spacer through covalent 
links [82] or a system containing the FRET pair and the recognition element in a controlled 
environment [83]. 
5. FRET based Ion sensor 
FRET based detection has become a powerful tool for quantitative measurements of 
various analytes such as H+ [84], metal ions [85, 86] and glucose [87] in environmental, 
industrial, medical, and biological applications because of its sensitivity, specificity, and real 
time monitoring with fast response time [88]. Recently Dibyendu et al [89] reported a method for 
the sensing of ions by determining the concentration of corresponding salts (KCl, NaCl, MgCl2, 
CaCl2, FeCl3, FeSO4, AlCl3) in water, based on FRET between two laser dyes Acriflavine and 
Rhodamine B. The principle of the proposed sensor is based on the change of FRET efficiency 
between the dyes in presence of different ions (K+, Na+, Mg2+, Ca2+, Fe2+, Fe3+, Al3+). Nano-
dimensional clay platelet laponite was used to enhance the efficiency of the sensor. 
Transition metal ions play an important role in biology as nutritional microelements as 
well as important ligands in proteins and small molecules. Sensing transition metal ions in 
biological systems is very crucial. The monitoring of toxic metal ions in aquatic ecosystems is an 
important issue because these contaminants can have severe effects on human health and the 
environment [90]. Lead and mercury are two of the most toxic metallic pollutants; for example, 
lead can cause renal malfunction and inhibit brain development [91] and mercury can damage 
the brain, heart, and kidneys [92]. Mercury pollution is a global problem and the major source of 
human exposure stems from contaminated natural waters [93]. Mercury undergoes long-range 
transport in the environment among various media such as air, soil, and water by deposition from 
anthropogenic releases. The atmospheric oxidation of mercury vapor to water-soluble Hg2+ ions 
and its subsequent metabolism by aquatic microbes produces methyl mercury, a potent 
neurotoxin linked to many cognitive and motion disorders [94]. Thus, obtaining new mercury 
detection methods that are cost effective, rapid, facile and applicable to the environmental and 
biological milieus is an important goal. Liu et al [95] reported FRET based ratiometric sensor for 
the detection of Hg2+ ion. Silica nanoparticles were labeled with a hydrophobic fluorescent 
nitrobenzoxadiazolyl dye which acts as a FRET donor. Rhodamine was then covalently linked to 
the surface of the silica particles which acts as acceptor. Nanoparticles are then exposed to Hg2+ 
in water. The detection limit of this is 100 nM (ca. 20 ppb). FRET based system with control 
over the location of both donor and acceptor and their separation distance within the 
nanoparticles has been developed for ratiometric sensing of Hg2+ in water [96]. A novel calyx(4) 
arene derivative locked in the 1,3-alternate conformation bearing two pyrene and rhodamine 
fluorophores was synthesized as a selective sensor for the Hg2+ ion [97]. The principle of sensing 
was based on FRET from pyrene excimer emissions to ring opened rhodamine absorption upon 
complexation of the Hg2+ ion. 
Chao et al reported FRET based ratiometric detection system for mercury ions in water 
with polymeric particles as scaffolds [98]. A flexible 8-hydroxyquinoline benzoate linked 
Bodipy-porphyrin dyad has been designed, synthesized which can be used for selectively sensing 
of Fe2+ and Hg2+ ions [99]. 
 
 
 
Figure 2. Formation of a FRET based system with polymeric nanoparticle as the Scaffold and its 
application as ratiometric fluorescence sensors for Mercury ion in water [98]. 
FRET-based ratiometric sensing platform based on β-cyclodextrin has been demonstrated 
[100]. β-cyclodextrin provides the hydrophilicity and biocompatibility; thus, the sensing 
platform can be used in aqueous medium and in some biological fluids as well as in live cells. 
Cyclodextrin based supramolecular complex has also been used for ratiometric sensing of ferric 
ion [101]. Cr3+ ion is an essential trace element in human nutrition and has great impacts on the 
metabolism of carbohydrates, fats, proteins and nucleic acids by activating certain enzymes and 
stabilizing proteins and nucleic acids [102]. Based on the FRET from naphthalimide and 
rhodamine, Cr3+-selective fluorescent probe for monitoring Cr3+ in living cells with ratiometric 
fluorescent methods has been developed [103] 
 
Figure 3. Mechanism of Cr3+ -selective sensor [103] 
 
A novel metal ion FRET sensor for potassium determination based on an ion-selective 
crown ether and energy transfer from carbon dots to graphene [104]. 
 
 
 
Figure 4. Schematic illustration of the FRET model based on carbon dots – graphene and the 
mechanism of K+ determination [104]. 
Rhodamine based reversible chemosensor capable of undergoing excimer-fluorescent 
resonance energy transfer (Em-FRET) was designed to sense carboxylate anions using a ditopic 
receptor strategy [105]. Intramolecular FRET from the naphthalene emission to the coumarin 
absorption has been used to design ion sensor, which affords high fluorescence selectivity toward 
F- and Cs+ ions [106]. Sensor containing guanidiniocarbonylpyrrole and a 9-(aminomethyl) 
anthracene moiety has been synthesized, which exhibits ratiometric fluorescence changes for 
SO32- over other anions. The change in fluorescence is attributed to the FRET and the SO32- 
complex induced photochemical reaction [107]. 
FRET based sensors have the potential to create time dependent concentration or activity 
maps of ions, small ligands, or macromolecules in living cells. In order to meet the challenge of 
multidimensional visualization, the dynamic range and response kinetics of the biosensors are 
critical attributes, since they directly affect the sensor’s spatial and temporal resolution. Time-
resolved microfluidic flow cytometer capable of characterizing the FRET based dynamic 
response of metal-ion sensors in mammalian cells has been designed [108]. The instrument can 
be used to examine the cellular heterogeneity of Zn2+ and Ca2+ sensor FRET response signals. 
Almost 30 fold difference between the extracellular and intracellular sensors has been reported 
[108]. FRET based Cd2+ indicator containing a Cd2+ binding protein obtained from Pseudomonas 
putida as the Cd2+ sensing key has been reported capable of live cell dynamic sensing of Cd2+ 
[109]. 
6. FRET based hard water sensor 
The mineral content of “hard water” is very high in compared to “soft water”. Though 
hard water is not harmful to one’s health generally, but can cause serious problems in industrial 
settings, where water hardness should be monitored to avoid breakdowns of the costly 
equipments that handle water. The hardness of water is determined by the concentration of 
multivalent cations in water. The most common cations found in hard water include Ca2+ and 
Mg2+. The temporary hardness in water involves the presence of dissolved carbonate minerals 
(CaCO3 and MgCO3), which can be reduced either by boiling the water or by addition of lime 
(calcium hydroxide) [110]. On the other hand the dissolved chloride minerals (CaCl2 and MgCl2) 
cause the permanent hardness of water that can not be removed easily, because it becomes more 
soluble as the temperature increases [111]. In that sense it is very important to identify the 
permanent hardness of water before use. Now a day the involvement of absorption or 
fluorescence spectroscopy for water analysis has received particular attention [112]. Sweetser 
and Bricker were the first who used the spectroscopic measurements to determine the 
concentration of calcium and magnesium ions in water [112]. Ion chromatography (IC) is 
another very powerful method for the analyses of anions and cations in aqueous solution [113]. 
Argüello and Fritz reported a method for the separation of Ca2+ and Mg2+ in hard water samples 
based on ion-chromatography and spectroscopic method [114]. E. Gömez et al reported a method 
for the simultaneous spectroscopic determination of calcium and magnesium using a diode-array 
detector [115]. The Fluorescence resonance energy transfer (FRET) phenomenon may be very 
effective tool for the designing of hard water sensors. Our group has designed a hard water 
sensor using FRET process [8]. To the best of our knowledge this could be the first attempt, 
where FRET process has been used for the detection of the hardness of water.  
 
Figure 5. FRET efficiency of Acf and RhB mixture for the different concentration of CaCl2 + 
MgCl2 in presence of clay 
 
In this case the effect of Mg2+ or Ca2+ or both on the FRET efficiency between two 
fluorophores, acraflavine (Acf) and rhodamine B (RhB) in presence of nanoclay sheet laponite 
has been investigated. The investigation showed that FRET efficiency decreases with increasing 
ion (Mg2+ or Ca2+ or both) concentration. This is because both the dyes Acf and RhB used were 
cationic in nature. Inclusion of cations increases the separation between them resulting a 
decrease in FRET efficiency. Nano clay platelet laponite was used to enhance the sensing 
efficiency. It has also been demonstrated that with proper calibration, this sensor can be used to 
sense water hardness with sufficient resolution between soft water (salt concentration less than 
0.06 mg/ml), moderately hard water (salt concentration greater than 0.06 mg/ml and less than 
0.12 mg/ml) and the hard water (salt concentration above 0.12 mg/ml) [110, 111]. 
7. FRET based pH sensors 
The sensing of pH is one of the most powerful techniques which are essential in many 
fields of application ranging from agriculture and environment to industry, medicine and food. In 
medical science, abnormal pH values inside the cell indicate inappropriate cell function, growth 
and division. It is also helpful to diagnose some common disease like cancer and Alzheimer’s. 
For the sensing of pH there are two very well known methods namely, (1) Optical chemical 
sensors (also termed optrodes) and (2) FRET based pH sensors. In case of optrodes the change in 
absorbance or fluorescence intensity of the pH sensitive dyes indicate a change in pH of the 
environment. On the other hand FRET based pH sensors are indicated by the ratiometric changes 
of the dye fluorescence of both donor and acceptor with pH of the environment.  
Optrodes exploit pH indicator dyes (weak organic acids or bases) with distinct optical 
properties associated with their protonated (acidic) and deprotonated (basic) forms [116]. The 
absorption or fluorescence properties of these dyes are modified with a change of pH of the 
environment. A schematic representation of absorption- and emission-based sensing is shown in 
figure. 
 
Figure 6. Schematic representation of the principle of (A) absorption based and (B) 
fluorescence-based pH sensing mechanisms [116]. 
 
There has been a consistent increase in output related to the development and application 
of optrodes since 1980. Apart from the overview sections, this review is exclusively focused on 
optical chemical pH sensors which have been developed in the last 2 years (2011−2013). Lin 
covers in his review different indicators, materials, and strategies for optical pH sensing 
published between 1991 and 2000. Fluorescent pH indicators offer better selectivity and 
sensitivity than absorption-based pH indicators. A review of fluorescent pH indicators has been 
published recently [117]. The most widely used fluorescent pH indicators are: 1-hydroxypyrene- 
3,6,8-trisulfonic acid (HPTS), fluorescein, and derivatives [118-120]. These dyes usually absorb 
in the visible blue region while emission occurs above 500 nm. pH sensors using the 
seminaphthofluorescein (SNAFL) have been also reported [121]. The fluorescein and SNAFL 
indicators exhibit poor photostability. HPTS exhibits excellent photostability, but its pH response 
is highly dependent on the ionic strength. pH-dependent lanthanide complexes have been also 
reported [122-125]. In 2007, novel pH sensitive coumarin-based indicators were described [126]. 
pH sensitive ruthenium metal−ligand complexes were also tested for use as luminescent pH 
indicators [127, 128]. Recently, Tormo et al. discussed the suitability of such complexes to be 
used as pH sensitive indicators [129].  
Fluorescent sensors are one of the important methods for sensing of different chemical 
and biological materials but for this type of sensors change in fluorescent intensity could very 
well be perturbed by environmental factors. The introduction of FRET sensors can minimize this 
environmental perturbation, because it measures the ratio of two emissions in different 
environment. Energy transfer has been used for pH measurement [130]. Chan et al. demonstrated 
Förster resonance energy transfer (FRET)-based ratiometric pH nanoprobes where they used 
semiconducting polymer dots as a platform. The linear range for pH sensing of the fluorescein-
coupled polymer dots was between pH 5.0 and 8.0 [131]. Egami et al. has introduced a fiber 
optic pH sensor, using polymer doped with either Congo red (pH range 3 to 5) or methyl red (pH 
range from 5 to 7) [132]. pH sensor based on the measurement of absorption of phenol red has 
also been reported [133], which can sense a pH range of 7 – 7.4. In one of our developed system 
of pH measurement using the change in FRET efficiency between Acf and RhB with pH we are 
capable of measuring over a wide range of pH 3.0 to 12.0 [9]. pH dependence of spectral overlap 
integral and FRET efficiency have been shown in figure 7. Sensing of wide range of pH using 
the present system is advantageous with respect to previous system [130]. 
 
Figure 7. Variation of (a) spectral overlap integral ( )(λJ ) and (b) energy transfer efficiency (E) 
with increasing pH of the solution [9]. 
Intracellular pH is an important indicator for cellular metabolism and pathogenesis [131, 
134]. pH sensing in living cells has been achieved using a number of synthetic organic dyes and 
genetically expressible sensor proteins, even allowing the specific targeting of intracellular 
organelles. Semiconducting polymer-based nanoparticles (Pdots) have recently emerged as a 
new class of ultrabright probes for biological detection and imaging. Poly (2,5-di(30,70-
dimethyloctyl) phenylene-1,4-ethynylene) (PPE) Pdots has been used as a platform for designing 
FRET based ratiometric pH nanoprobes [131]. Where, a pH-sensitive dye, fluorescein was 
coupled to PPE Pdots offering a rapid and robust sensor for pH determination using the 
ratiometric methodology where excitation at a single wavelength results in two emission peaks, 
one that is pH sensitive and the other one that is pH insensitive for use as an internal reference. 
The linear range for pH sensing of the fluorescein-coupled Pdots is between pH 5.0 and 8.0, 
which is suitable for most cellular studies. The pH-sensitive Pdots show excellent reversibility 
and stability in pH measurements. This sensor has tested to measure the intracellular pH in HeLa 
cells following their uptake by endocytosis, thus demonstrating their utility for the use in cellular 
and imaging experiments [131]. pH lameleons are prototypes of a new class of pH sensors that 
can be further optimized, tuned, and targeted to different subcellular structures or attached to 
target proteins to interrogate pH changes in cellular microdomains [135]. pH lameleons possess 
ideal properties for intracellular pH measurements; they provide highly enhanced spectral 
dynamics compared to previous genetically encodable biosensors and offer fast and quantitative 
detection, with all the flexibility of genetically encodable biosensors. Esposito et al [135] 
reported a FRET-based pH sensor platform, based on the pH modulation of YFP acceptor 
fluorophores in a fusion construct with ECFP. Quantum dot-fluorescent protein FRET Probes for 
the sensing intracellular pH has been demonstrated [136] having high sensitivity and wide 
dynamic range, ratiometric measurements for internal calibration, dramatic reduction of 
photobleaching, and the ability to tailor the probe design for different pH ranges. These probes 
are well suited to a wide range of intracellular pH-dependent imaging applications that are not 
feasible with fluorescent proteins or organic fluorophores alone. 
 
 
Figure 8. Schematic demonstration of the pH-dependent energy transfer between the quantum 
dot and fluorescent protein [121]. 
 
Semiconductor nanocrystals (NCs) serve as useful fluorescent labels owing to their 
photostability, continuous absorption spectra, and efficient, narrow, and tunable emission [137]. 
These properties of NCs have been exploited for applications in biological imaging and in single 
particle tracking studies [138]. A Ratiometric CdSe/ZnS Nanocrystal pH Sensor has also been 
reported [139, 140]. Taken together with the broad excitation spectrum and photostability 
conferred by NCs, the reversible and ratiometric approach presented here makes NCs versatile 
agents for chemical and biological sensing [139]. A new pH-sensitive polymeric sensor with 
dispersion stability and biocompatibility is synthesized, and its pH sensitivity is examined on the 
basis of the FRET efficiency [141]. 
 
8. FRET based Biosensors 
Molecular activities in human body are highly dynamic and can occur locally in sub-
cellular domains or compartments. Neighboring cells in the same tissue can exist in different 
states. Therefore, quantitative information on the cellular and sub-cellular dynamics of ions, 
signaling molecules, and metabolites is critical for functional understanding of organisms. 
Biosensors are the devices that can measure enzyme activities, protein dynamics, and biophysical 
processes (e.g., membrane potential or molecular tension) or detect any disease related molecules 
using biological recognition element with sub-cellular resolution [142, 143]. Disease related 
molecules may be antibodies, antigens, nucleic acids or other biologically relevant small 
molecules, which are markers for a particular disease or condition [142, 143]. The biological 
recognition elements contain biomolecules such as antibodies, DNA probes or enzymes, which 
recognize a particular disease marker or analyte. The reaction between the biomolecule and the 
analyte results in physical or chemical changes that can result in the production of heat, mass, 
light, electrons or ions [144]. The analyte can also be labeled with a biomarker or tag, such as an 
enzyme, radioisotope or dye. If the dye is fluorescent, the device is then known as a 
fluorescence-based biosensor. The Pico-Quant GmbH system is an example of a very sensitive 
fluorescence based biosensor. It utilizes fluorescence decay lifetimes and it is possible to detect a 
single fluorescent molecule and its orientation with this system [145]. There is a demand for 
simple, compact, low-cost devices that can detect a low concentration of antigens. There are a 
few strategies being employed to enhance the sensitivity of fluorescence-based biosensors to 
achieve this goal. One of these strategies is FRET [146].  
Quantitative and dynamic analysis of metabolites and signaling molecules is limited by 
technical challenges in obtaining temporally resolved information at the cellular and 
compartmental level. FRET technology enables the quantitative analysis of molecular dynamics 
in biophysics and in molecular biology, such as the monitoring of protein-protein interactions, 
protein-DNA interactions, and protein conformational changes. FRET-based biosensors have 
been utilized to monitor cellular dynamics not only in heterogeneous cellular populations, but 
also at the single-cell level in real time. Lately, applications of FRET-based biosensors range 
from basic biological to biomedical disciplines. Despite the diverse applications of FRET, 
FRET-based sensors still face many challenges. There is an increasing need for higher 
fluorescence resolution and improved specificity of FRET biosensors [147]. Additionally, as 
more FRET-based technologies extend to medical diagnostics, the affordability of FRET 
reagents becomes a significant concern.  
In order to deduce the molecular mechanisms of biological function, it is necessary to 
monitor changes in the sub-cellular location, activation, and interaction of proteins within living 
cells in real time. Fo ሷrster resonance energy-transfer (FRET)- based biosensors that incorporate 
genetically encoded, fluorescent proteins permit high spatial resolution imaging of 
protein−protein interactions or protein conformational dynamics. RhoA is a member of the Rho 
family, a subset of the Ras superfamily of GTP-binding proteins. RhoA is of central importance 
in the regulation of contractility and cell interaction with the extracellular matrix4. It serves as a 
molecular switch that cycle between a GDP-bound inactive state and a GTP-bound active state. 
Yousaf et al [148] reported a FRET-Based Biosensor to study the dynamics of RhoA GTPase 
activation in cells on patterned substrates. 
The phenomenon of FRET between two fluorescent proteins of different hues provides a 
robust foundation for the design and construction of biosensors for the detection of intracellular 
events. Accordingly, FRET-based biosensors for a variety of biologically relevant ions, 
molecules, and specific enzymatic activities, have now been developed and used to investigate 
numerous questions in cell biology [142]. 
The most successful and highly exploited strategy to date in ratiometric multi-parameter 
fluorescence imaging has been to combine the use of a CFP/YFP FRET biosensor with a 
synthetic Ca2+ indicator. Fortunately, several popular Ca2+ indicators, including fura-2 and indo-
1, either absorb or fluoresce at wavelengths that are distinct from that of the CFP/YFP pair [149]. 
Determination of infected or disease-related biomolecules in body fluids such as serum or 
plasma holds significant applications in clinical diagnosis. FRET based sensor has been designed 
and applied to monitor thrombin level in human plasma [150]. FRET from upconverting 
phosphors (UCP) to carbon nanoparticles (CNP) has been used to design this sensor. The sensor 
can be used for thrombin sensing both in an aqueous buffer and in a serum matrix with 
comparable performances, proving that the UCP-CNP FRET system is capable of overcoming 
background interference in complex biological samples [150]. 
 
Figure 9. Schematic illustration of the Thrombin Sensor Based on FRET from Aptamer-
Modified Upconverting Phosphors to Carbon Nanoparticles [150]. 
 
Matrix metalloproteinases (MMPs) are a family of zinc dependent endopeptides that 
degrades the extracellular matrix and basement membrane components. Specifically, MMP-2 
(gelatinase A) is able to degrade type VI collagen and thus not only plays a key role in 
physiological and pathological states including morphogenesis, reproduction, and tissue 
remodeling, but also is one of the crucial MMPs in tumor growth, invasion, and metastasis [151, 
152]. Due to the high complexity of the sample matrix, sensitive and selective determination of 
MMP-2 directly in blood samples is very difficult and a challenging job. Liu et al [153] has 
designed a new homogeneous biosensor for selective sensing of MMP-2 based on FRET from 
upconversion phosphors (UCPs) to carbon nanoparticles (CNPs). They also developed  new 
upconversion FRET sensing platform using aromatic polymer nanospheres (poly-m-
phenylenediamine, PMPD) as the energy acceptor [154], which may open the door for the new 
class of UC-FRET biosensors with wide applications [154]. 
Genetically-encoded FRET biosensors enable us to visualize a variety of signaling 
events, such as protein phosphorylation and G protein activation in living cells [155, 156]. 
Biosensors based on the principle of FRET have been developed to visualize the activities of the 
signaling molecules in living cells. Accordingly, FRET based biosensors have been used in 
cancer research [157]. Stable expression of FRET biosensors will accelerate current trends in 
cancer research, that is, from cells on a plastic dish to 3-D and/or live tissues, and from 
biochemistry to live imaging. A sensitive and specific FRET biosensor was developed by 
Mizutani et al [158] and applied to detect the activity of BCR-ABL kinase in live cells. This 
biosensor allowed the detection of cancerous and drug-resistant cells, and the evaluation of 
kinase inhibitor efficacy. This is an indication that future biosensor development and imaging 
using FRET can increasingly contribute to cancer diagnosis and therapeutics. 
 
Figure 10. The application of a FRET biosensor for drug screening. Cancer (red) and normal 
(blue) cells from biopsy samples can be introduced with FRET biosensors to detect cancerous 
molecular activities, for example, BCR_ABL kinase activity. FRET scanning can identify the 
cancer cells and quantify their cancerous activities on the basis of the FRET signals. The biopsy 
samples and cells expressing the biosensors can be subjected to different drug treatments to 
assess the efficacy of different drugs in inhibiting the target molecular activities [158]. 
 
Simultaneous monitoring of multiple molecular interactions and multiplexed detection of 
several diagnostic biomarkers at very low concentrations have become important issues in 
advanced biological and chemical sensing. Optically multiplexed six-color FRET based 
biosensor for simultaneous monitoring of five different individual binding events has been 
reported [159]. Simultaneous FRET from one Tb complex to five different organic dyes 
measured in a filter-based time-resolved detection format with a sophisticated spectral crosstalk 
correction, which results in very efficient background suppression. The advantages and 
robustness of the multiplexed FRET sensor were exemplified by analyzing a 15-component lung 
cancer immunoassay involving 10 different antibodies and five different tumor markers in a 
single 50 µL human serum sample. Quantum-dot based FRET immunoassay for sensitive clinical 
diagnostics of low volume serum samples has also been demonstrated [160]. 
Schifferer et al [161] demonstrated a genetically encoded dynamic RNA reporter using 
intramolecular FRET between mutants of GFP. This may be useful in several types of 
application, for example, as reporter in vitro for real time studies on transcription or stability of 
RNA, to image very dynamic aspects of gene expression in vivo or to study relationships 
between RNA levels and protein expression in single living cells. FRET based biosensor has also 
been used for monitoring the σ1 receptor activation switch in living cells [162]. 
The use of conjugated polymers as biosensor devices is a growing research field, and the 
detection of small quantities of biomolecules is of great interest. Areas in which detection of 
DNA is of interest are for example forensic science, medical diagnostics, and the study of 
mutations. Indeed, the genomic revolution creates a great need for cheap methods for DNA 
detection and decoding. One approach to DNA detection is to use the special properties of 
conjugated polymers, which can respond to external stimuli, such as biomolecules, with a change 
in fluorescence spectra. Detection of specific DNA sequences has important applications in 
clinical diagnosis, the food and drug industry, pathology, genetics, and environmental 
monitoring. 
One of the important methods for detecting the DNA hybridization method is by 
measuring the fluorescence signals, where the dye molecules are intercalated in to a DNA double 
helix [163]. But some inherent limitations of this method include a lack of specificity for many 
particular duplex and no possibility to create multiplexed assays [163]. Another most important 
strategy for the detection of DNA hybridization involves FRET. There are many reports where 
the detection and characterization of DNA involves FRET process. K. Fujimoto et al reported the 
detection of target DNAs by excimer-monomer switching of Pyrene using the FRET process 
[164]. DNA based nanomachine was reported by H. Liu et al using the FRET phenomenon 
[165]. Also for encrypting messages on DNA strands, various methods have been accomplished 
[166].  
Influence of DNA presence on FRET efficiency between two laser dyes Acf and RhB has been 
studied [10]. Two types of molecular logic gates, namely, NOT and YES/NOT gate have been 
designed based on the FRET between Acf and RhB. These two molecular logic gates have been 
found efficient to detect the presence of DNA in aqueous solution having concentration as low as 
1 µg/ml [10]. 
 
Figure 11. (a) Molecular structure of rhodamine B, (b) molecular structure of acriflavine, (c) 
structure of DNA showing the negatively charged phosphate deoxyribose backbone, (d) 
schematic diagram showing the attachment of Acf & RhB onto phosphate backbone of DNA 
[10]. 
 
The interactions between a zwitterionic polythiophene derivative, POWT, and DNA 
oligonucleotides in solution have been studied by FRET in order to demonstrate a DNA sensor 
[167]. A DNA biosensor based on FRET utilizing synthesized quantum dot (QD) has been 
developed for the detection of specific-sequence of DNA for Ganoderma boninense, an oil palm 
pathogen [168]. Detection of target DNA based on FRET has been demonstrated [169], where, 
introduction of graphene helped to reduce the background signal of traditional PFP-based DNA 
detection platform and thus enhances the sensing efficiency. 
 
Figure 12. Schematic Representation of GO-Based Low Background-Signal Platform for the 
Detection of Target DNA [169]. 
 
Metal dependent global folding and activity of the 8-17 DNAzyme has been studied by 
FRET [170]. It has been shown that DNAzyme folds into compact structure(s) in the presence of 
Zn2+ or Mg2+ with stem III approaching a configuration constituting stems I and II without 
changing the angle between stems I and II. Activity, folding and Z-DNA formation of the 8-17 
DNAzyme has also been studied in presence of monovalent ions [171]. 
Protein−DNA interactions play central roles in many biological processes. Studying 
sequence specific protein−DNA interactions and revealing sequence rules require sensitive and 
quantitative methodologies that are capable of capturing subtle affinity difference with high 
accuracy and in a high throughput manner. Double stranded DNA-conjugated gold nanoparticles 
and water-soluble conjugated polyelectrolytes are used as cooperative sensing elements to 
construct a suit of hybrid sensors for detecting protein−DNA interactions, exploiting the 
differential FRET with and without protein binding [172]. 
 
Figure 13. Schematic illustration of DNA detection, showing the conformational changes of 
dye−oligonucleotide−AuNP conjugates before and after hybridization with the target DNA 
[173]. 
Hairpin FRET-based systems for sensing DNA have been created by labeling molecular 
beacons with AuNPs. As shown in Figure 13, the nucleic acid sensor conjugated with the organic 
dye is self-complementary, forming the hairpin structure on AuNPs with effective FRET 
fluorescence quenching. The hairpin structure changes to rodlike through complementary 
hybridization with the target DNA, resulting in an increase in fluorescence of the dye. By 
employing similar principle, Nie et al. have shown that single stranded oligonucleotide-
functionalized AuNPs with fluorophore-termini can assemble into a constrained arch-like 
conformation [174]. Mirkin et al. have developed AuNPs sensors, which are designed to detect 
and quantify intracellular analytes, for example, mRNA in cells [175]. 
 
The condensation and decondensation of DNA can be efficiently detected by FRET 
studies. Recently usefulness of intermolecular two-step FRET has been demonstrated [176], 
from quantum dots (QDs) on DNA to first a nucleic acid labeling dye and then Cy5 dye on the 
condensing agent, for the detection of DNA condensation [177]. Zhang et al have shown that 
water-soluble Cysteine-coated CdSe/ZnS QDs are capable of sensing the dissociation of 
DNA/polymer polyplexes [178]. The main advantage of these methods is that donors and 
acceptors labeled beyond the Förster distance in a DNA molecule precisely report the changes in 
the intramolecular conformation, the degree of condensation, and the stability of the condensed 
DNA [179, 180]. 
Phenomenon of FRET has been used to study DNA hybridization and cleavage 
processes. The hybridization was monitored by following FRET between Quantum Dots (QDs) 
and a molecular fluorophores (figure 14), [179, 181] whereas treatment of the QD/dye- DNA 
structure with deoxyribonuclease (DNase I) cleaved the DNA duplex and restored the 
fluorescence properties [182]. In general, FRET-based photodecomposition of excess acceptors 
in the proximity of highly photostable donors such as QDs will be helpful during the preparation 
of labeled DNA and other biomolecules for the analyses of not only DNA condensation and gene 
delivery but also protein-protein and protein-DNA interactions in biophysical investigations. 
 
 
Figure 14.  Hypothesis about FRET-mediated photodecomposition of undesired acceptors 
followed by the sensitive detection of the condensed DNA in a solution and decondensed DNA 
in a cell. The large number of acceptors left unaffected beyond the Förster distance can 
sensitively report the condensation of DNA by FRET-RAP [183]. 
 
Diabetes mellitus is a disease of major global concern, increasing in frequency at almost 
epidemic rates, such that the worldwide prevalence is predicted to at least double to about 300 
million people over the next 10–15 years [184]. Diabetes is characterised by a chronically raised 
blood glucose concentration (hyperglycaemia), due to a relative or absolute lack of the pancreatic 
hormone, insulin. Therefore, control of glucose in blood is crucial for the long-term health of 
diabetics [185]. Continuous glucose monitoring (CGM) entered into clinical practice in 1999. 
Genetically encoded glucose nanosensors have been used to measure steady state glucose levels 
in mammalian cytosol, nuclei, and endoplasmic reticulum [186] Nevertheless, the performance 
of glucose sensors is widely thought to be a major bottleneck in the development of a closed-
loop insulin delivery system (artificial pancreas) [187] where the clinical and regulatory 
requirements are for optimal accuracy and reliability of the CGM component. 
Present methods to measure glucose require fresh blood, which is obtained by a finger 
stick. This procedure is painful and inconvenient, making it difficult to determine the glucose 
level in blood as frequently as is needed. Erratic blood glucose levels due to diabetes are 
responsible for adverse long-term problems of blindness and heart disease. These effects are 
thought to be due to glycosylation of protein in blood vessels. Consequently, there have been 
continued efforts to develop a noninvasive means to measure blood glucose and to develop 
fluorescence methods to detect glucose. These have often been based on the glucose-binding 
protein concanavalin A (ConA) and a polysaccharide, typically dextran, which serves as a 
competitive ligand for glucose (Figure 15a). Typically, the ConA is labeled with a donor (D) and 
the dextran with an acceptor (A), but the labels can be reversed. Binding of D-ConA to A-
dextran results in a decrease in donor intensity or lifetime. The glucose in the sample competes 
for the glucose binding sites on D-ConA, releasing D-ConA from the acceptor. The intensity 
decay time and phase angles of the donor are thus expected to increase with increasing glucose 
concentration. This principle was used in the first reports of glucose sensing by fluorescence 
intensities. A fiber-optic glucose sensor was made using FITC-labeled dextran and rhodamine-
labeled ConA (Figure 15b). The acceptor could be directly excited as a control measurement to 
determine the amount of Rh-ConA. The response of this glucose sensor is shown in Figure 15c. 
The donor and acceptor were placed on the dextran and ConA, respectively. The donor 
fluorescence was not completely recovered at high concentrations of glucose. This lack of 
complete reversibility is a problem that plagues ConA-based glucose sensors to the present day. 
It is expected that these problems can be solved using alternative glucose binding proteins, 
especially those that have a single glucose binding site and may be less prone to irreversible 
associations. It seems probable that site-directed mutagenesis will be used to modify the glucose-
binding proteins to obtain the desired glucose affinity and specificity. As might be expected, 
lifetime-based sensing has been applied to glucose, and has been accomplished using 
nanosecond probes, long-lifetimes probes, and laser-diode-excitable probes. The problem of 
reversibility has been addressed by using sugar-labeled proteins in an attempt to minimize 
crosslinking and aggregation of the multivalent ConA. Such glucose sensors are occasionally 
fully reversible, but there is reluctance to depend on a system where reversibility is difficult to 
obtain. 
a 
b c 
Figure. 15.  Glucose sensing by resonance energy transfer. (a) Revised from [196], (b) Revised 
from [196], (c) Revised from [197]. 
 
Hsieh et al [188] demonstrated that multiple cysteines is a member of the periplasmic 
binding protein family can be selectively labeled with two different thiol-reactive reagents. This 
technique exploits a protein conformational change upon binding of a ligand, thus blocking one 
of the cysteine sites from the reaction chemistry. Using this technique for sequential labeling of 
glucose/galactose binding protein with the two dyes nitrobenzoxadiazole and Texas Red, two 
functional FRET sensors were prepared, and a glucose-dependent FRET signal was 
demonstrated for each of these. The ligand protection strategy may be of value for many further 
applications where dual-labeling of proteins is desired. 
Dysfunction of endothelial cells under high glucose concentration is one of the major 
concerns for hyperglycemia [189]. A novel endothelial cell apoptosis detection method, which 
combines a caspase-3-based FRET biosensor cell line and the microfluidic chip system, was 
developed. The apoptosis and necrosis of endothelial cells undergo a series of different pulsatile 
flow conditions and glucose concentrations can be detected with high accuracy since the FRET 
biosensor provides real-time observation and does not need post treatment [190]. 
 Precise and dynamic measurement of intracellular metabolite levels has been hampered 
by difficulties in differentiating between adsorbed and imported fractions and the sub-cellular 
distribution between cytosol, endomembrane compartments and mitochondria. Genetically 
encoded FRET based sensors were deployed for dynamic measurements of free cytosolic glucose 
and ATP at varying external supply and in glucose transport mutants [191]. These FRET sensors 
in a microfluidic platform, capable to monitor in vivo changes in intracellular free glucose in 
individual yeast cells. FRET based optical sensors for monitoring dynamic changes of 
intracellular metabolite levels in mammalian cells has also been reported [192]. Veetil et al [193] 
developed a new glucose sensor protein, AcGFP1-GBPcys-mCherry, and an optical sensor 
assembly, capable of generating quantifiable FRET signals for glucose monitoring [193]. This 
glucose sensor can generate measureable FRET signals in response to glucose concentrations 
varying from 25 to 800 µM. The possibility to measure glucose in vivo in the subconjunctival 
interstitial fluid for a period of 2 weeks was demonstrated in a human clinical trial [194]. It has 
been observed that a biocompatible surface coating on the implantable ocular mini implant 
enabled a longer duration of action of up to 6 months compared with 3 months for uncoated 
implants for in vivo glucose monitoring [195]. 
 
9. Conclusion and outlook 
The present article has summarized recent developments of FRET based sensors with 
emphasis on biosensors. FRET is a unique phenomenon that combines the sensitivity and 
selectivity of fluorescence with the strong dependence of FRET on the distance between donor 
and acceptor molecules as well as their orientation. FRET is undoubtedly a powerful 
bioanalytical technique capable of making precise intramolecular measurements in a variety of 
experimental platforms and formats. Recent dramatic improvements in the development of 
fluorophores, such as fluorescent proteins and nanoparticles, along with the availability of 
advanced optical detection capabilities have enhanced the strength of this technique and resulted 
in its increasing popularity. Unlike with those of single signal sensors, the ratiometric FRET 
sensors eliminate most ambiguities in the detection by self-calibration of two emission bands of 
two different fluorophores. External factors, such as excitation source fluctuations and sensor 
concentration, will not affect the ratio between the two fluorescence intensities. 
The demand for highly sensitive nonisotopic and noninvasive bioanalysis systems for 
biotechnology applications, such as those needed in clinical diagnostics, food quality control, 
and drug delivery, has driven research in the use of FRET for biological and chemical 
applications. Development of FRET based sensing system for practical application is a 
challenge, requiring an interdisciplinary outlook. Future progress of research in the area of FRET 
sensor is dependent upon the close collaboration of physicists, chemists, biologists, material 
scientists and computing specialists. 
 
Acknowledgements: 
The author SAH is grateful to DST and CSIR for financial support to carry out this 
research work through DST Fast-Track project Ref. No. SE/FTP/PS-54/2007, CSIR project Ref. 
03(1146)/09/EMR-II. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reference 
1. J. R Lakowicz, Principles of Fluorescence Spectroscopy (3rd ed.), Springer, New York (2006). 
2. C. Ma, F. Zeng, L. Huang, and S. Wu, J. Phys. Chem. B 115 (2011) 874. 
3. A. R. Clap, I. L. Medintz, and H. Mattoussi, Phys. Chem. Chem. Phys. 7 (2006) 47. 
4. T. Pons, I. L. Medintz, K. E. Sapsford, S. Higashiya, A. F. Grimes, D. S. English, and H. 
Mattoussi,.Nano Lett. 7 (2007) 3157. 
5. T. Pons, I. L. Medintz, X. Wang, and H. Mattoussi, J. Am. Chem. Soc. 128 (2006) 15324. 
6. X. L. Zhang, Y. Xiao, X. H. Qian, Angew. Chem. 47 (2008) 8025. 
7. H. Ueyama, M. Takagi, and S. Takenaka, J. Am. Chem. Soc. 124 (2002) 14286. 
8. D. Dey, D. Bhattacharjee, S. Chakraborty, and S. A. Hussain, Sens. Actuators B 184 (2013) 
268. 
9. D. Dey, D. Bhattacharjee, S. Chakraborty, and S. A Hussain, J. Photochem. Photobiol. A 
 Chemistry 252 (2013) 174. 
10. D. Bhattacharjee, D. Dey, S. Chakraborty, S. A. Hussain, and S. Sinha, J. Biol. Phys. 39 
(2013) 387. 
11. C. Gengwen, S. Fengling, X. Xiaoqing, and P. Xiaojun, Ind. Eng. Chem. Res. 52 (2013) 
11228. 
12. D. M. Chudakov, S. Lukyanov, and K. A. Lukyanov, Trends Biotechnol. 23 (2005) 605. 
13. B. N. Giepmans, S. R. Adams, M. H. Ellisman, and R. Y. Tsien, Science 312 (2006) 217. 
14. A. Miyawaki, Developmental Cell 4 (2003) 295. 
15. J. Zhang, R. E. Campbell, A. Y. Ting, and R. Y Tsien, Nat. Rev. Mol. Cell. Biol. 3 (2002) 
906. 
16. B. A. Pollok and R. Heim, Trends Cell. Biol. 9 (1999) 57. 
17. V. G. Kozlov, V. Bulovic, P. E. Burrows, and S. R. Forrest, Nature 389 (1997) 362. 
18. C. R. Cantor, P. R. Schimmel, Biophysical Chemistry (Part-II), Freeman, San Francisco 
(1980) 
19. K. E. Sapsford, L. Berti, and I. L. Medintz, Angew. Chem. 45 (2006) 4562. 
20. S. A. Hussain, S. Chakraborty, D. Bhattacharjee, and R. A. Schoonheydt, Spectrochim. Acta 
Part A 75 (2010) 664. 
21. P. M. W. French, Biosensors 12 (1999) 41. 
22. M. J. Cole, S. E. D. J. W. Siegel, R. Jones, K. Dowling, M. J. Dayal, D. Parsons, P. M. 
French, M. J. Lever, L. O. Sucharov, M. A. Neil, R. Juskaitis, and T. Wilson, J Microsc 203 
(2001) 246. 
23. G. Haran, Journal of Physics: Condensed Matter 15 (2003) R1291. 
24. R. B. Best, S. B. Flower, J. L. T. Herrera, and J. Clark, Proceedings of the National Academy 
of Sciences of the United States of America 99 (2002) 12143. 
25. B. Zagrovic, C. D. Snow, S. Khaliq, M. R. Shirts, and V. S. Pande, J. Mol. Biol. 323 
(2002).153. 
26. R. J. H. Clark, R. E. Hester (Eds.), Advances in Spectroscopy, Wiley, New York (1996). 
27. M. S. Csele, P. Engs, Fundamentals of Light and Lasers, Wiley, New York (2004). 
28. J. M. Drake, J. Klafter, and P. Levitz, Science 251 (1991) 1574. 
29. Y. Yilmaz, A. Erzan, and Ö. Pekcan, Phys. Rev. E 58 (1998) 7487. 
30. T. Jonsson, C. D. Waldburger, and R. T. Sauer, Biochemistry 35 (1996) 4795. 
31. B. S. Watson, T. L. Hazlett, J. F. Eccleston, C. Davis, D. M. Jameson, and A. E. Johnson, 
Biochemistry 34 (1995) 7904. 
32. K. M. Parkhurst and L. J. Parkhurst, Biochemistry 34 (1995) 285. 
33. J. W. Nichols and R. E. Pagano, J. Bio. Chem. 258 (1983) 5368. 
34. N. L. Rosi and C. A. Mirkin, Chem. Rev. 105 (2005) 1547. 
35. E. M. Nolan and S. J. Lippard, Chem. Rev. 108 (2008) 3443. 
36. J. Han and K. Burgess, Chem. Rev. 110 (2010) 2709. 
37. H. Wang, D. Wang, Q. Wang, X. Li, and C. A. Schalley, Org. Biomol. Chem. 8 (2010) 1017. 
38. S. C. Dodani, Q. He, and C. J. Chang, J. Am. Chem. Soc. 131 (2009) 18020. 
39. H. Takakusa, K. Kikuchi, Y. Urano, S. Sakamoto, K. Yamaguchi, and T. Nagano, J. Am. 
Chem. Soc. 124 (2002) 1653. 
40. H. N Kim,.; M. H Lee,.; H. J Kim,.; J. S Kim, and J. Yoon, Chem. Soc. Rev. 37 (2008) 1465. 
41. R. Y. Tsien, and M. Poenie, Trends Biochem. Sci. 11 (1986) 450. 
42. Y. Kubo, M. Yamamoto, M. Ikeda, M. Takeuchi, S. Shinkai, S. Yamaguchi, and K. Tamao, 
Angew. Chem., 42 (2003) 2036. 
43. A. Ajayaghosh, P. Carol, and S. Sreejith, J. Am. Chem. Soc. 127 (2005) 14962. 
44. Y. Zhou, C. Y. Zhu, X. S. Gao, X. Y. You, and C. Yao, Org. Lett. 12 (2010) 2566. 
45. S. K. Kim, K. Swamy, S. Y. Chung, H. N. Kim, M. J. Kim, Y. Jeong, and J. Yoon, 
Tetrahedron Lett. 51 (2010) 3286. 
46. H. Z. Liu, P. Yu, D. Du, C. Y. He, B. Qiu, X. Chen, and G. A. Chen, Talanta 81 (2010) 433. 
47. M. Suresh, S. Mishra, S. K. Mishra, E. Suresh, A. K. Mandal, A. Shrivastav, and A. Das, 
Org. Lett. 11 (2009) 2740. 
48. B. P. Joshi, J. Park, W. I. Lee, and K. H. Lee, Talanta 78 (2009) 903. 
49. X. L. Zhang, Y. Xiao, and X. H. Qian, Angew. Chem., 47 (2008) 8025. 
50. H. Ueyama, M. Takagi, and S. Takenaka, J. Am. Chem. Soc. 124 (2002) 14286. 
51. G. Q. Shang, X. Gao, and H. Zheng, J Fluoresc. 18 (2008) 1187. 
52. Y. Jun, L. Changhua, W. Di, and L. Shiyong, J. Phys. Chem. B, 114 (2010) 12213. 
53. D. Maity, D. Karthigeyan, T. K. Kundu, and T. Govindaraju, Sens. Actuators, B Chemical 
176 (2013) 831. 
54. J. M. Ingram, C. Zhang, J. Xu, and S. J. Schiff, J. Neurosci Methods 214 (2013) 45 
55. I. L. Medintz, K. E. Sapsford, A. R. Clapp, T. Pons, S. Higashiya, J. T. Welch, and H. 
Mattoussi, J. Phys. Chem. B 110 (2006) 10683. 
56. I. L. Medintz, S. A. Trammell, H. Mattoussi, and J. M. Mauro, J. Am. Chem. Soc. 126 (2004) 
30. 
57. G. Chen, Y. Jin, L. Wang, J. Deng, and C. Zhang, Chem. Commun. 47 (2011) 12500. 
58. Z. Zhou, M. Yu, H. Yang, K. Huang, F. Li, T. Yi, and C. Huang, Chem. Commun. 29 (2008) 
3387. 
59. K. Wang, Z. Tang, C. J. Yang, Y. Kim, X. Fang, W. Li, Y. Wu, C. D. Medley, Z. Cao, J. Li, 
P. Colon, H. Lin, and W. Tan, Angew. Chem. 48 (2009) 856. 
60. U. H. F. Bunz, and V. M. Rotello, Chem. Int. Ed. 49 (2010) 3268. 
61. B. Tang, N. Zhang, Z. Chen, K. Xu, L. Zhuo, L. An, and G. Yang, Chemistry 14 (2008) 522. 
62. B. Y. Wu, H. F. Wang, J. T. Chen, and X. P. Yan, J. Am. Chem. Soc. 133 (2011) 686. 
63. Y. Chen, M. B. O’Donoghue, Y. F. Huang, H. Kang, J. A. Phillips, X. Chen, M. C. Estevez, 
C. J. Yang, and W. Tan,. J. Am. Chem. Soc. 132 (2010) 16559. 
64. S. H. Kim, M. Jeyakumar, and J. A. Katzenellenbogen, J. Am. Chem. Soc. 129 (2007) 13254. 
65. J. Lei, L. Wang, and J. J. Zhang, Chem. Commun. 46 (2010) 8445. 
66. J. Chen, F. Zeng, S. Wu, J. Zhao, Q. Chen, and Z. Tong, Chem. Commun. (2008) 5580. 
67. M. Q. Zhu, L. Zhu, J. J. Han, W. Wu, J. K. Hurst, and A. D. Q. Li, J. Am. Chem. Soc. 128 
(2006) 4303. 
68. E. S. Childress, C. A. Roberts, D. Y. Sherwood, C. L. M. LeGuyader, E. J. Harbron, 84 
(2012) 1235. 
69. J. Perrin, Academie des Sciences 184 (1927) 1097. 
70. T. H. Förster, Z. Naturforsch., 4A (1949) 321. 
71. T. H. Förster, in Modern quantum chemistry Istanbul lectures (Part 3), Action of light and 
organic crystals, Academic Press, ed. O. Sinanoglu, New York (1965). 
72. T. Förster, Modern Quantum Chemistry. (Part 2). Action of Light and Organic Molecules, 
Academic, New York (1965). 
73. J. R. Lakovitz, Principles of Fluorescence Spectroscopy, Kluwer Academic/Plenum, New 
York (1999). 
74. M. Pope, C. E. Swenberg, Electronic Processes in Organic Crystals, Oxford University Press, 
New York (1982). 
75. D. Seth, D. Chakrabarty, A. Chakraborty, and N. S. Sarkar, Chem. Phys. Lett. 401 (2005) 
546. 
76. F. R. Lipsett, Prog. Dielectr. 7 (1967) 217. 
77. D. Ghosh, D. Bose, D. Sarkar, and N. Chattopadhyay, J. Phys. Chem. A 113 (2009) 10460. 
78. S. A. Hussain, S. Chakraborty, D. Bhattacharjee, and R. A. Schoonheydt, Spectrochim Acta 
Part A 75 (2010) 664. 
79. V. K. Sharma, P. D. Sahare, R. C. Rastogi, S. K. Ghoshal, and D. Mohan, Spectrochim. Acta 
Part A 59 (2003) 1799. 
80. V. Misra, H. Mishra, H. C. Joshi, T. C. Pant, Sens. Actuators B 63 (2000) 18. 
81. Y. H. Chan, C. Wu, F. Ye, Y. Jin, P. B. Smith, and D. T. Chiu, Anal. Chem. 83 (2011) 1448. 
82. K. Okamoto and M. Terazima, J. Phys. Chem. B 112 (2008) 7308. 
83. J. I. Peterson, S. R. Goldstein, R. V. Fitzgerald, D. K. Buckhold, Anal Chem. 52 (1980) 864. 
84. A. Almutairi, S. J. Guillaudeu, M. Y. Berezin, S. Achilefu, and J. M. J. Fréchet, J. Am. 
Chem. Soc. 130 (2008) 444. 
85. P. Scrimin, P. Tecilla, U. Tonellato, and T. Vendrame Langmuir 17 (2001) 7521. 
86. D. Mansell, N. Rattray, L. Etchells, C. Schwalbe, A. Blake, E. V. Bichenkova, R. A. Bryce, 
C. Barker, A. Díaz, C. Kremer, and S. Freeman, Chem. Commun. 41 (2008) 5161. 
87. D. B. Cordes, S. Gamsey, Z. Sharrett, A. Miller, P. Thoniyot, R. A. Wessling, and B. 
Singaram, Langmuir 21 (2005) 6540. 
88. M. Merzlyakov, E. Li, and R. Casas, and K. Hristova, Langmuir 22 (2006) 6986. 
89. D. Dey, J. Saha, A. D. Roy, D. Bhattacharjee, and Syed Arshad Hussain, Sens. Actuators, B 
Chemical 195 (2014) 382. 
90. H. Needleman, Annu. Rev. Med. 55 (2004) 209. 
91. H. L. Needleman, Human Lead Exposure; CRC Press: Boca Raton, FL (1991). 
92. I. Hoyle, and R. D. Handy, Aquat. Toxicol. 72 (2005) 147. 
93. M. A. Chamjangali, S. Soltanpanah, and N. Goudarzi, Sens. Actuators B Chem. 138 (2009)  
251. 
94. T.W. Clarkson, L. Magos, and G.J. Myers, Engl J Med 349 (2003) 1731. 
95. L. Baoyu, Z. Fang, and W. Shuizhu, Microchimica Acta 180 (2013) 845. 
96. L. Baoyu, Z. Fang, W. Guangfei, and W. Shuizhu, Chem. Commun. 47 (2011) 8913 
97. R. Correia and P. DeShong, J. Org. Chem. 75 (2010) 7159. 
98. M. Chao, Z. Fang, H. Lifang, and W. Shuizhu, J. Phys. Chem. B 115 (2011) 874. 
99. C. Yuting, W. Liang, Y. Xiang, L. Wenjun, B. Yongzhong, and J. Jianzhuang, Org. Lett. 21 
(2011) 5774. 
100. F. Gang, X. Meiyun, Z. Fang, and W. Shuizhu, Langmuir 26 (2010) 17764. 
101. X. Meiyun, W. Shuizhu, Z. Fang, and Y. Changmin, Langmuir 26 (2010) 4529. 
102. R. Anderson and R. A. Chromium, Academic Press, New York (1987). 
103. Z. Zhou, M. Yu, H. Yang, K. Huang, F. Li, T. Yi, and C. Huang, Chem. Commun. (2008) 
3387. 
104. W. Wei, C. Xu, J. Ren, B. Xu,  and X. Qu, Chem. Commun. 48 (2012) 1284. 
105. C. Kaewtong, J. Noiseephum, Y. Uppa, N. Morakot, N. Morakot, B. Wanno, T. Tuntulanic, 
and B. Pulpokac, New J. Chem. 34 (2010) 1104. 
106. M. H. Lee, D. T. Quang, H. S. Jung, J. Yoon, C. H. Lee, and J. S. Kim, J. Org. Chem. 72 
(2007) 4242. 
107. Y. Sun, C. Zhong, R. Gong, H. Mu, and E. Fu, J. Org. Chem. 74 (2009) 7943. 
108. H. Ma, E. A. Gibson, P. J. Dittmer, R. Jimenez, and A. E. Palmer, J. Am. Chem. Soc. 134 
(2012) 2488. 
109. T. Y. Chiu, P. H. Chen, C. L. Chang, and D. M. Yang, PLOS one 8 (2013) e65853. 
110. H. Weingärtner, Water in Ullmann's Encyclopedia of Industrial Chemistry, Wiley–VCH, 
Weinheim (2006). 
111. T. J. Sorg, R. M. Schock, and D. A. Lytle, J. Am. Water Works Assoc. 91 (1999) 85. 
112. P. B. Sweetser and C. E. Bncker, Anal. Chem. 26 (1954) 195. 
113. H. Small, T. S. Stevens,and W. C. Bauman, Anal. Chem. 47 (1975) 1801. 
114. M. D. Argiiello and J. S. Fntz, Anal. Chem. 49 (1977) 1595. 
115. E. Gómez, J. M. Estela, and V. Cerdà, Anal. Chim. Acta 249 (1991) 513. 
116. E. Bishop (Ed.), Indicators. Pergamon Press, Oxford. 1972. 
117. J. Hans and K. Burgess, Chem. Rev. 110 (2010) 2709. 
118. S. Hulth, R. C. Aller, P. Engström, E. Selander, Limnol. Oceanogr. 47 (2002) 212. 
119. Q. Z. Zhu, R. C. Aller, and Y. Fan, Environ. Sci. Technol. 39 (2005) 8906. 
120. H. R. Kermis, Y. Kostov, P. Harms, and G. Rao, Biotechnol. Prog. 18 (2002) 1047. 
121. K. Aslan, J. R. Lakowicz, H. Szmacinski, and C. D. Geddes, J Fluoresc. 15 (2005) 37. 
122. M. Turel, M. Cajlakovic, Ed. Austin, J. P. Dakin, G. Uray, A. Lobnik, Sens. Actuators, B 
131 (2008) 247. 
123. R. Pal and D. Parker, Org. Biomol. Chem. 6 (2008) 1020. 
124. S. Blair, M. P. Lowe, C. E. Mathieu, D. Parker, P. K. Senanayake, and R. Kataky, Inorg. 
Chem. 40 (2001) 5860. 
125. T. Gunnlaugsson, Tetrahedron Lett. 42 (2001) 8901. 
126. A. S. Vasylevska, A. A. Karasyov, S. M. Borisov, and C. Krause, Anal. Bioanal. Chem. 387 
(2007) 2131. 
127. H. J. Kim, Y. C. Jeong, J. Heo, J. II. Rhee, K. J. Hwang, Bull. of the Kor. Chem. Soc. 30 
(2009) 539. 
128. Y. Clarke, W. Xu, J. N. Demas, and B. A. DeGraff, Anal. Chem. 72 (2000) 3468. 
129. L. Tormo, N. Bustamante, G. Colmenarejo, and G. Orellana, Anal. Chem. 82 (2010) 5195. 
130. V. Misra, H. Mishra, H.C. Joshi, and T. C. Pant, Sens. Actuators B 63 (2000) 18. 
131. Y. H. Chan, C. Wu, F. Ye, Y. Jin, P. B. Smith, and D. T. Chiu, Anal. Chem. 83 (2011) 
1448. 
132. C. Egami, Y. Suzuki, O. Sugihora, H. Fujimura, N. Okamoto, Jpn. J. Appl. Phys. 36 (1997) 
2902. 
133. J. I. Peterson, S. R. Goldstein, and R. V. Fitzgerald, Anal. Chem. 52 (1980) 864. 134. R. 
Freeman, J. Girsh, and I. Willner, ACS Appl. Mater. Interfaces 5 (2013) 2815. 
135. A. Esposito, M. Gralle, M. Angela, C. Dani, D. Lange, and F. S. Wouters, Biochemistry 47 
(2008) 13115. 
136. M. Dennis, W. J. Rhee, D. Sotto, S. N. Dublin, and G. Bao, ACS Nano. 6 (2012) 2917. 
137. X. Michalet, F. F. Pinaud, L. A. Bentolila, J. M. Tsay, S. Doose, J. J. Li, G. Sundaresan, A. 
M. Wu, and S. S. Gambhir, S. Weiss Science 307 (2005) 538. 
138. S. Pouya, M. Koochesfahani, P. Snee, M. Bawendi, and D. Nocera, Exp. Fluids 39 (2005) 
784. 
139. J. D. Krooswyk, C. M. Tyrakowski, and P. T. Snee, J. Phys. Chem. C 114 (2010) 21348. 
140. P. T. Snee, R. C. Somers, G. Nair, J. P. Zimmer, M. G. Bawendi, and D. G. Nocera, J. Am. 
Chem. Soc. 128 (2006) 13320. 
141. S. W. Hong, C. H. Ahn, J. Huh, and W. H. Jo, Macromolecules 39 (2006) 7694. 
142. R. E. Campbell, Anal. Chem. 81 (2009) 5972. 
143. S. Zadran and D. Geffen, Appl. Microbiol. Biotechnol. 96 (2012) 895. 
144. A. T. Iavarone, D. Duft, and J. H. Parks, J. Phys. Chem. A 110 (2006) 12714. 
145. Z. Gao, H. Deng, W. Shen, and Y. Ren, Anal. Chem. 85 (2013) 1624. 
146. S. Okumoto, A. Jones, W. B. Frommer, Annu. Rev. Plant Biol. 63 (2012) 663. 
147. B. Chaudhuri, F. Ho¨rmann, and W. B. Frommer, J. Exp. Bot. 62 (2011) 2411. 
148. L. Hodgson, E. W. L. Chan, K. M. Hahn, and M. N. Yousaf, J. Am. Chem. Soc. 129 (2007) 
9264. 
149. G. Grynkiewicz, M Poenie, and R Y Tsien, J. Biol. Chem. 260 (1985) 3440. 
150. Y. Wang, L. Bao, Z. Liu, and D. W. Pang, Anal. Chem. 83 (2011) 8130. 
151. R. Edwards and G. Murphy, Nature 394 (1998) 527. 
152. G. Giannelli, J. Falk-Marzillier, O. Schiraldi, W. G. Stetler-Stevenson, V. Quaranta, Science 
277 (1997) 225. 
153. Y. Wang, P. Shen, C. Li, Y. Wang, and Z. Liu, Anal. Chem. 84 (2012) 1466. 
154 L. Xie, Y. Qin, and H. Y. Chen, Anal. Chem. 85 (2013) 2617. 
155. G. Chen, F. Song, X. Xiong, and X. Peng, Ind. Eng. Chem. Res. 52 (2013) 11228. 
156. A. Miyawaki, J. Am. Chem. Soc. 4 (2003) 295. 
157. K. Aoki1, N. Komatsu1, E. Hirata, Y. Kamioka, and M. Matsuda, Cancer Sci. 103 (2012) 
614. 
158. S. Lu1 and Y. Wang, Clin. Cancer Res. 16 (2010) 3822. 
159. D. Geißler, S. Stufler, H. G. Löhmannsröben, and N. Hildebrand, J. Am. Chem. Soc. 135 
(2013) 1102. 
160. K. D. Wegner, Z. Jin, S. Linde´n, T. L. Jennings, and N. Hildebrandt, ACS Nano. 7 (2013) 
7411. 
161. M. Schifferer and O. Griesbeck, J. Am. Chem. Soc. 134 (2012) 15185. 
162. M. G. Soler, V. F. Dueñas, E. P. Salido, P. Pérez, D. Zamanillo, J. M. Vela, J. Burgueño, 
and F. Ciruela, J. Med. Chem. 57 (2014) 238. 
163. J. D. Watson and F. H. C. Crick, Nature 171 (1953)737. 
164. K. Fujimoto, H. Shimizu, and M. Inouye, J. Org. Chem. 69 (2004) 3271. 
165. H. Liu, Y. Zhou, Y. Yang, W. Wang, L. Qu, C. Chen, D. Liu, D. Zhang, and D. Zhu, J. 
Phys. Chem. B 112 (2008) 6893. 
166. C. Mao, T. H. LaBean, J. H. Reif, and N. C. Seeman, Nature 407 (2000) 493. 
167. F. K. Karlsson, P. Asberg, K. P. R. Nilsson, and O. Inganäs, Chem. Mat. 17 (2005) 4204. 
168. N. M. Bakhori, N. A. Yusof, A. H. Abdullah, and M. Z. Hussein, Biosensors 3 (2013) 419. 
169. X. J. Xing, X. G. Liu, Y. He, Y. Lin, C. L. Zhang, H. W. Tang, and D.W. Pang, 
Biomacromolecules 14 (2013) 117. 
170. H. K. Kim, J. Liu, J. Li, N. Nagraj, M. Li, C. M. B. Pavot, and Y. Lu, J. Am. Chem. Soc. 
129 (2007) 6896. 
171. D. Mazumdar, N. Nagraj, H. K. Kim, X. Meng, A. K. Brown, Q. Sun, W. Li, and Y. Lu, J. 
Am. Chem. Soc. 131 (2009) 5506. 
172. S. Lukman, K. M. M. Aung, J. Liu, B. Liu, and X. Su, ACS Appl. Mater. Interfaces 5 
(2013) 12725. 
173. P. C. Ray, A. Fortner, and G. K. Darbha, J. Phys. Chem. B 110 (2006) 20745. 
174. D. J. Maxwell, J. R. Taylor, and S. Nie, J. Am. Chem. Soc. 124 (2002) 9606. 
175. A. E. Prigodich, D. S. Seferos, M. D. Massich, D. A. Giljohann, B. C. Laneand, and C. A. 
Mirkin, ACS Nano.3 (2009) 2147. 
176. H. H. Chen, Y. P. Ho, X. Jiang, H. Q. Mao, T. H. Wang, and K. W. Leong, Nano Today 4 
(2009) 125. 
177. C. L Grigsby, Y. P. Ho, and K. W Leong, Nanomedicine (Lond.) 7 (2012) 565. 
178. B. Zhang, Y. Zhang, S. K. Mallapragada, and A. R. Clapp, ACS Nano 5 (2011) 129. 
179. K. Boeneman, J. R. Deschamps, S. B. White, D. E. Prasuhn, J. B. B. Canosa, P. E. Dawson, 
M. H. Stewart, K. Susumu, E. R. Goldman, M. Ancona, and I. L. Medintz, ACS Nano. 4 (2010) 
7253. 
180. C. R. Simmons, D. Schmitt, X. Wei, D. Han, A. M. Volosin, D. M. Ladd, D. K Seo, Y. Liu, 
and H. Yan, Acs Nano. 5 (2011) 6060. 
181. V. Biju, A. Anas, H. Akita, E. S. Shibu, T. Itoh, H. Harashima, and M. Ishikawa, ACS 
Nano. 6 (2012) 3776. 
182. T. Qiu, D. Zhao, G. Zhou, Y. Liang, Z. He, Z. Liu, X. Peng, and L. Zhou, Analyst 135 
(2010) 2394. 
183. Ashton Action, Issues in Nanoscience and Nanoscale Research, Scholarly Editions, Atlanta, 
Georgia (2013). 
184. H. King, R. E. Aubert, and W. H. Herman, Diab. Care 21 (1998) 1414. 
185. E. Peel, U. Griffiths, and S. Jones, Diabet. Med. 24 (2007) 97. 
186. K. Deuschle, B. Chaudhuri, S. Okumoto, I. Lager, S. Lalonde, W. B. Frommer, Plant Cell. 
18 (2006) 2314. 
187. R. Hovorka, Nat Rev Endocrinol 7 (2011) 385. 
188. H. V. Hsieh, D. B. Sherman, S. A. Andaluz, M.S. Terry, J. Amiss, J. B. Pitner, J Diabetes 
Sci Technol 6 (2012) 1286. 
189. I. A. M. van den Oever, H. G. Raterman, M. T. Nurmohamed, and S. Simsek, Mediators 
Inflamm. 1 (2010) 792393. 
190. Q. Yu, X. F. Liu, L. K. Chin, A. Q. Liua, and K. Q. Luo, Lab Chip 13 (2013) 2693. 
191. B. H. Hou, H. Takanaga, G. Grossmann, L. Q. Chen, X. Q. Qu, A. M Jones, S. Lalonde, O. 
Schweissgut, W. Wiechert, and W. B Frommer, Nature Protocols 6 (2011) 1818. 
192. I. Medintz, N. Hildebrandt, FRET - Förster Resonance Energy Transfer: From Theory to 
Applications, Wiley-VCH, Germany (2014). 
193. J. V. Veetil, S. Jin, and K. Ye, Biosens. Bioelectron. 26 (2010) 1650. 
194. A. J. Müller, M. Knuth, K. S. Nikolaus, and P. Herbrechtsmeier, J. Diabetes Sci. Technol. 6 
(2012) 875. 
195. A. J. Müller, M. Knuth, K. S. Nikolaus, R. Krivánek, F. Küster, C. Hasslacher, G. U. 
Auffarth, J Diabetes Sci. Technol. 7 (2013) 24. 
196. J. R. Lakowicz, Plenum Press, New York 4 (1994). 
197. J. Schultz, S. Mansouri, and I. J. Goldstein, Diabetes Care 5 (1982) 245. 
